New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
All news
Rethink Medical strengthens its R&D team to advance T-Control® development
Rethink Medical has welcomed Industrial Engineer Alba Jiménez Martel to strengthen its innovation team and contribute to the development of a new catheterisation solution aimed at addressing complex urinary catheterisation situations. The project includes the design and development of a new catheter tip and is supported through the IPI programme.
Her recruitment is supported by a €42,835.68 grant, 85% co-financed by the European Social Fund Plus (ESF+) under the Canary Islands ESF+ Programme 2021–2027.
Project: Development of an optimised catheter tip to expand the applicability of T-Control® in patients with complex urinary catheterisation. Beneficiary: Rethink Medical, S.L.
More news
Rethink Medical presents T-Control® at the 48th Spanish Neuroscience Nursing Congress
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Rethink Medical reaches the minimum target of its 2026 investment round
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.